Corrigendum to "Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation", [Biomaterials, 33, (2012), 5854-5864], doi: 10.1016/j.biomaterials.2012.04.062;Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation

Biomaterials

Volumn 33, Issue 24, 2012, Pages 5854-5864

  Sun, Yang ^a   Zheng, Yuanyi ^a   Ran, Haitao ^a   Zhou, Yang ^a   Shen, Hongxia ^a   Chen, Yu ^b   Chen, Hangrong ^b   Krupka, Tianyi M ^c   Li, Ao ^a   Li, Pan ^a   Wang, Zhibiao ^a   Wang, Zhigang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer therapy; HIFU; MRI; PLGA; Ultrasound imaging

Indexed keywords

ABLATION; BIOCOMPATIBILITY; DISEASES; EFFICIENCY; EMULSIFICATION; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAGNETITE; MICROSTRUCTURE; NANOPARTICLES; SUPERPARAMAGNETISM; SURGERY; ULTRASONIC IMAGING;

CANCER THERAPY; HIFU; HIGH INTENSITY FOCUSED ULTRASOUND; INORGANIC NANOPARTICLE; PLGA; POLY(LACTIC-CO-GLYCOLIC ACID); THERAPEUTIC EFFICIENCY; ULTRASOUND IMAGING;

MEDICAL IMAGING;

CONTRAST MEDIUM; POLYGLACTIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; COMPOSITE MATERIAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; EMULSION; EVAPORATION; HIGH INTENSITY FOCUSED ULTRASOUND; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MICROCAPSULE; NANOENCAPSULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; TARGET ORGAN; TUMOR ABLATION; TUMOR XENOGRAFT;

ORYCTOLAGUS CUNICULUS;

EID: 84861748149     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.06.021     Document Type: Erratum

References (32)

1. Acharya S., Sahoo S.K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 2011, 63:170-183.
2. Wheatley M.A., Forsberg F., Oum K., Ro R., El-Sherif D. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent. Ultrasonics 2006, 44:360-367.
3. Xu J.S., Huang J., Qin R., Hinkle G.H., Povoski S.P., Martin E.W., et al. Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. Biomaterials 2010, 31:1716-1722.
4. Schweiger C., Pietzonka C., Heverhagen J., Kissel T. Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging. Int J Pharm 2011, 408:130-137.
5. Ling Y., Wei K., Luo Y., Gao X., Zhong S. Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. Biomaterials 2011, 32:7139-7150.
6. Liu Z.Y., Wang Y., Liang C.H., Li X.H., Wang G.Y., Liu H.J., et al. In vitro labeling of mesenchymal stem cells with superparamagnetic iron oxide by means of microbubble-enhanced US exposure: initial experience. Radiology 2009, 253:153-159.
7. Sun C., Lee J.S., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008, 60:1252-1265.
8. Yang F., Li Y., Chen Z., Zhang Y., Wu J., Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 2009, 30:3882-3890.
9. Burtea C., Laurent S., Mahieu I., Larbanoix L., Roch A., Port M., et al. In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. Contrast Media Mol Imaging 2011, 6:236-250.
10. Orsi F., Arnone P., Chen W., Zhang L. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors. J Cancer Res Ther 2010, 6:414-420.
11. Lynn J.G., Zwemer R.L., Chick A.J., Miller A.E. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 1942, 26:179-193.
12. Gelet A., Chapelon J.Y., Poissonnier L., Bouvier R., Rouviere O., Curiel L., et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004, 63:625-629.
13. Chan A.H., Fujimoto V.Y., Moore D.E., Held R.T., Paun M., Vaezy S. In vivo feasibility of image-guided transvaginal focused ultrasound therapy for the treatment of intracavitary fibroids. Fertil Steril 2004, 82:723-730.
14. Esnault O., Franc B., Menegaux F., Rouxel A., De Kerviler E., Bourrier P., et al. High-intensity focused ultrasound ablation of thyroid nodules: first human feasibility study. Thyroid 2011, 21:965-973.
15. Illing R.O., Kennedy J.E., Wu F., ter Haar G.R., Protheroe A.S., Friend P.J., et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 2005, 93:890-895.
16. Hynynen K., Pomeroy O., Smith D.N., Huber P.E., McDannold N.J., Kettenbach J., et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001, 219:176-185.
17. Orgera G., Monfardini L., Della Vigna P., Zhang L., Bonomo G., Arnone P., et al. High-intensity focused ultrasound (HIFU) in patients with solid malignancies: evaluation of feasibility, local tumour response and clinical results. Radiol Med 2011, 116:734-748.
18. Wu F., Wang Z.B., Chen W.Z., Wang W., Gui Y., Zhang M., et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem 2004, 11:149-154.
19. Yang L., Peng X.H., Wang Y.A., Wang X., Cao Z., Ni C., et al. Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res 2009, 15:4722-4732.
20. Kennedy J.E. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005, 5:321-327.
21. ter Haar G. Ultrasound focal beam surgery. Ultrasound Med Biol 1995, 21:1089-1100.
22. Li Y.Y., Sha W.H., Zhou Y.J., Nie Y.Q. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2007, 22:2148-2154.
23. Li J.J., Xu G.L., Gu M.F., Luo G.Y., Rong Z., Wu P.H., et al. Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors. World J Gastroenterol 2007, 13:2747-2751.
24. Wu F., Wang Z.B., Chen W.Z., Zhu H., Bai J., Zou J.Z., et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 2004, 11:1061-1069.
25. Chen Y., Chen H., Sun Y., Zheng Y., Zeng D., Li F., et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew Chem Int Ed Engl 2011, 50:12505-12509.
26. Wang X., Chen H., Chen Y., Ma M., Zhang K., Li F., et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater 2012, 24:785-791.
27. Ao M., Wang Z., Ran H., Guo D., Yu J., Li A., et al. Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent - a feasibility research. J Biomed Mater Res B Appl Biomater 2010, 93:551-556.
28. Jain S., O'Hagan D.T., Singh M. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant. Expert Rev Vaccines 2011, 10:1731-1742.
29. Chen J.H., Ling R., Yao Q., Li Y., Chen T., Wang Z., et al. Effect of small-sized liposomal Adriamycin administered by various routes on a metastatic breast cancer model. Endocr Relat Cancer 2005, 12:93-100.
30. Luo W., Zhou X., Tian X., Ren X., Zheng M., Gu K., et al. Enhancement of ultrasound contrast agent in high-intensity focused ultrasound ablation. Adv Ther 2006, 23:861-868.
31. Yu T., Xiong S., Mason T.J., Wang Z. The use of a micro-bubble agent to enhance rabbit liver destruction using high intensity focused ultrasound. Ultrason Sonochem 2006, 13:143-149.
32. Kaneko Y., Maruyama T., Takegami K., Watanabe T., Mitsui H., Hanajiri K., et al. Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue. Eur Radiol 2005, 15:1415-1420.